Effect Of Caveolin-1 On Human Laryngeal Cancer Cell Proliferation And Egfr Signaling Pathway

Heqing Li,Huowang Liu,Yanhong Ma,Yexun Song,Ru Gao,Guolin Tan

2016-01-01

Abstract:Primary laryngeal cancer refers to the cancer whose primary site is throat. Squamous cell carcinoma is the most common one. Caveolin-1 (CAV1) is an integral membrane protein, which is a main component of the microcapsules. It has been shown that CAV1 is closely linked with cancer. In this study, the effect of Caveolin-1 on human laryngeal cancer cell proliferation and EGFR signaling pathway was investigated. Seventy-eight patients diagnosed with laryngeal squamous cell carcinoma by our hospital from January 2012 to March 2015 were included in this study. Immunohistochemistry and RT-PCR were used to detect the expression level of CAV1 in both cancer tissues and adjacent tissues. CAV1 was overexpressed in Hep2 cells by transfection, MTT was used to measure the cells' proliferation and Western-Blot was used to detect the expression levels of p-EGFR and p-ERK1/2. Immunohistochemistry and RT-PCR results showed that positive expression rate of CAV1 in laryngeal carcinoma was significantly lower than that of adjacent tissues (P < 0.05), and the positive expression rate of CAV1 decreased along with the decrease of degree of tumor differentiation. Increase of CAV1 expression in Hep2 cells by transfection significantly decreased cell proliferation and lowered the expression levels of p-EGFR and p-ERK1/2 (P < 0.05). Compared with normal tissues, expression levels of CAV1 in laryngeal squamous carcinoma were low. Overexpression of CAV1 in laryngeal squamous carcinoma cells reduced cell proliferation possibly through inhibition of phosphorylation of EGFR and ERK1/2.